Skip to main content
News Directory 3
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Menu
  • Business
  • Entertainment
  • Health
  • News
  • Sports
  • Tech
  • World
Type 2 Diabetes and Blood Vessel Damage: A Silent Threat - News Directory 3

Type 2 Diabetes and Blood Vessel Damage: A Silent Threat

January 23, 2026 Jennifer Chen Health
News Context
At a glance
  • The study highlights a correlation between the duration of⁢ type 2 diabetes and the progress of⁣ damaging effects of red blood cells on⁢ blood vessel function, with significant...
  • MicroRNA-210 levels within⁤ red blood cells appear to play a crucial role in mediating the observed vascular damage in long-term diabetes.
  • Definition / Direct Answer: MicroRNA-210 is a small non-coding RNA molecule that regulates gene expression, and its levels in⁤ red blood ⁣cells are altered in long-standing type 2...
Original source: sciencedaily.com

Diabetes and Blood Vessel Dysfunction: A time-Dependent Effect

Table of Contents

  • Diabetes and Blood Vessel Dysfunction: A time-Dependent Effect
    • MicroRNA-210 and Blood Vessel Function
    • Karolinska Institutet Research Team
    • Potential Biomarker for Cardiovascular Risk

The study highlights a correlation between the duration of⁢ type 2 diabetes and the progress of⁣ damaging effects of red blood cells on⁢ blood vessel function, with significant changes occurring after several years of disease progression. This contrasts with findings in newly diagnosed patients, where red blood cells do⁤ not exhibit the same harmful properties. Karolinska Institutet news

MicroRNA-210 and Blood Vessel Function

MicroRNA-210 levels within⁤ red blood cells appear to play a crucial role in mediating the observed vascular damage in long-term diabetes. Restoring these levels in affected red blood cells has been shown to improve blood vessel function. Karolinska Institutet News

Definition / Direct Answer: MicroRNA-210 is a small non-coding RNA molecule that regulates gene expression, and its levels in⁤ red blood ⁣cells are altered in long-standing type 2 diabetes, contributing to blood vessel dysfunction.
Detail: ⁢ The research indicates that a ⁤decrease in microRNA-210 within red blood cells is associated with the development of damaging properties. This suggests a potential mechanism by wich chronic hyperglycemia impacts vascular health. The study used both animal models (mice) and human subjects to demonstrate this effect.
Example or Evidence: ‍ In the study, restoring microRNA-210 levels in red blood cells from both diabetic mice and patients improved blood vessel‍ function, demonstrating a causal link between microRNA-210 and vascular health. Karolinska Institutet News

Karolinska Institutet Research Team

The research was led by Zhichao Zhou,⁢ associate professor at the Department of Medicine, Solna, ⁢Karolinska Institutet, and Eftychia Kontidou, a doctoral student from the same group. Karolinska Institutet News

Definition / Direct Answer: Zhichao Zhou and Eftychia Kontidou led the research team at the Karolinska Institutet that investigated the link between diabetes duration, red blood cell function, and vascular damage.
Detail: The team conducted‍ studies on both animal models ‍and human patients with type 2 diabetes to understand the effects of the disease on red blood cell function⁣ and its impact ‍on blood⁣ vessels. Their findings emphasize⁣ the importance of disease duration in the⁢ development of these complications.
Example or Evidence: ‍ Zhichao Zhou stated, “what really stands out in our study is that it ⁣is indeed not only the presence of type 2 diabetes that matters, but how long you have had the disease. It is only after several years that red blood cells develop a harmful effect on ⁤blood vessels.” Karolinska Institutet News

Potential Biomarker for Cardiovascular Risk

The study suggests that⁣ microRNA-210 levels in red blood⁤ cells could serve ⁢as a biomarker⁣ for early detection of cardiovascular risk in individuals with type 2 ⁢diabetes. Karolinska Institutet News

Definition / Direct ⁢Answer: MicroRNA-210 ⁢in red blood cells is being⁤ investigated as a potential biomarker ⁢to identify individuals with ⁤type 2 diabetes who are at increased risk of developing ‍cardiovascular complications.
Detail: Early identification of at-risk patients could allow for proactive interventions ⁤to prevent or⁣ delay the onset⁢ of vascular damage. Researchers are planning larger population studies to validate the use⁣ of microRNA-210 as a clinical biomarker.
Example or Evidence: Eftychia Kontidou noted, “If we can identify which⁣ patients are at greatest risk before vascular damage has already occurred, we can also become better at preventing complications.” Karolinska Institutet News

Breaking News Check (2026/01/23 00:29:58): A search on Karolinska Institutet’s news page and PubMed for updates on this⁢ research as of the current date did ⁤not reveal any significant new developments⁢ or retractions. The findings ‍remain current as of this date.

Share this:

  • Share on Facebook (Opens in new window) Facebook
  • Share on X (Opens in new window) X

More on this

  • Samadi Warns About Silent Killers in Men
  • New Breathalyzer Device Accurately Measures Fat Burning Through Exhaled Air

Related

Heart Disease; Personalized Medicine; Cold and Flu; Alternative Medicine; Diseases and Conditions; Genes; Healthy Aging; Pharmacology

Search:

News Directory 3

News Directory 3 catalogs US newspapers, news services, newsstands and digital news outlets across all 50 states. Browse local publishers by city, state, or topic, and follow current headlines linked back to their original sources.

Quick Links

  • Disclaimer
  • Terms and Conditions
  • About Us
  • Advertising Policy
  • Contact Us
  • Cookie Policy
  • Editorial Guidelines
  • Privacy Policy

Browse by State

  • Alabama
  • Alaska
  • Arizona
  • Arkansas
  • California
  • Colorado

© 2026 News Directory 3. All rights reserved.
For contact, advertising, copyright, issues email: office@newsdirectory3.com